London
· Delayed Price · Currency is GBP · Price in USD Axsome Therapeutics Statistics
Total Valuation
LON:0HKF has a market cap or net worth of GBP 5.31 billion. The enterprise value is 5.22 billion.
| Market Cap | 5.31B |
| Enterprise Value | 5.22B |
Important Dates
The last earnings date was Thursday, February 20, 2025.
| Earnings Date | Feb 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +5.48% |
| Shares Change (QoQ) | +0.83% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 36.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -22.74 |
| EV / Sales | 17.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -50.76 |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 3.38.
| Current Ratio | 2.11 |
| Quick Ratio | 1.99 |
| Debt / Equity | 3.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.50 |
| Interest Coverage | -38.43 |
Financial Efficiency
Return on equity (ROE) is -231.63% and return on invested capital (ROIC) is -50.30%.
| Return on Equity (ROE) | -231.63% |
| Return on Assets (ROA) | -27.28% |
| Return on Invested Capital (ROIC) | -50.30% |
| Return on Capital Employed (ROCE) | -74.60% |
| Revenue Per Employee | 451,069 |
| Profits Per Employee | -335,900 |
| Employee Count | 545 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 2.16 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +65.27% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +65.27% |
| 50-Day Moving Average | 101.44 |
| 200-Day Moving Average | 89.75 |
| Relative Strength Index (RSI) | 74.02 |
| Average Volume (20 Days) | 1,864 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.15 |
Income Statement
In the last 12 months, LON:0HKF had revenue of GBP 308.08 million and -229.42 million in losses. Loss per share was -4.79.
| Revenue | 308.08M |
| Gross Profit | 281.48M |
| Operating Income | -201.64M |
| Pretax Income | -229.35M |
| Net Income | -229.42M |
| EBITDA | -195.28M |
| EBIT | -201.64M |
| Loss Per Share | -4.79 |
Balance Sheet
The company has 251.89 million in cash and 154.13 million in debt, giving a net cash position of 97.77 million.
| Cash & Cash Equivalents | 251.89M |
| Total Debt | 154.13M |
| Net Cash | 97.77M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 45.54M |
| Book Value Per Share | 0.94 |
| Working Capital | 203.65M |
Cash Flow
In the last 12 months, operating cash flow was -102.57 million and capital expenditures -215,668, giving a free cash flow of -102.79 million.
| Operating Cash Flow | -102.57M |
| Capital Expenditures | -215,668 |
| Free Cash Flow | -102.79M |
| FCF Per Share | n/a |
Margins
Gross margin is 91.37%, with operating and profit margins of -65.45% and -74.47%.
| Gross Margin | 91.37% |
| Operating Margin | -65.45% |
| Pretax Margin | -74.45% |
| Profit Margin | -74.47% |
| EBITDA Margin | -63.39% |
| EBIT Margin | -65.45% |
| FCF Margin | n/a |
Dividends & Yields
LON:0HKF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.48% |
| Shareholder Yield | -5.48% |
| Earnings Yield | -4.32% |
| FCF Yield | -1.93% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LON:0HKF has an Altman Z-Score of 1.71. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.71 |
| Piotroski F-Score | n/a |